Literature DB >> 17799238

Conglutination: Specific Inhibition by Carbohydrates.

M A Leon, R Yokohari.   

Abstract

Conglutination of antigen-antibody-complement complexes is inhibited by a number of acetamido sugars, the most efficient being N-acetyl-D-glucosamine and closely related compounds. The effects of structural modification on activity of N-acetyl-D-glucosamine are described.

Entities:  

Year:  1964        PMID： 17799238     DOI： 10.1126/science.143.3612.1327

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  6 in total

1.  Tissue localization of conglutinin, a bovine C-type lectin.

Authors:  U Holmskov; B Teisner; N T Pedersen; S B Laursen; H B Rasmussen; J C Jensenius
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

2.  Immunoconglutinins in human saliva--a group of unusual IgA antibodies.

Authors:  P J Lachmann; R A Thomson
Journal:  Immunology       Date:  1970-02       Impact factor: 7.397

3.  Two distinct serum mannose-binding lectins function as beta inhibitors of influenza virus: identification of bovine serum beta inhibitor as conglutinin.

Authors:  C A Hartley; D C Jackson; E M Anders
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

4.  Some properties of piglet, calf, pig and bovine conglutinin.

Authors:  H Tlaskalová; O Bárta
Journal:  Folia Microbiol (Praha)       Date:  1968       Impact factor: 2.099

5.  Bovine serum conglutinin is a lectin which binds non-reducing terminal N-acetylglucosamine, mannose and fucose residues.

Authors:  R W Loveless; T Feizi; R A Childs; T Mizuochi; M S Stoll; R G Oldroyd; P J Lachmann
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

6.  Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.

Authors:  G D Ross; S L Newman; J D Lambris; J E Devery-Pocius; J A Cain; P J Lachmann
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.